X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Sammaan Capital Ltd.
BSE CODE: 535789   |   NSE CODE: SAMMAANCAP   |   ISIN CODE : INE148I01020   |   22-Nov-2024 Hrs IST
BSE NSE
Rs. 155.85
-3.95 ( -2.47% )
 
Prev Close ( Rs.)
159.80
Open ( Rs.)
161.10
 
High ( Rs.)
161.70
Low ( Rs.)
155.35
 
Volume
859661
Week Avg.Volume
727548
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 155.79
-3.91 ( -2.45% )
 
Prev Close ( Rs.)
159.70
Open ( Rs.)
161.40
 
High ( Rs.)
161.62
Low ( Rs.)
155.19
 
Volume
6943026
Week Avg.Volume
10505864
 
52 WK High-Low Range(Rs.)
130.69
209.3
Source DateBoard Meeting DateDetails
11-Nov-2024 14-Nov-2024 Quarterly Results
26-Aug-2024 29-Aug-2024 Inter alia, to consider and approve:- (1) for convening 19th Annual General Meeting of the Company (19th AGM) and considering seeking shareholders? approval, for renewal of annual authorization for issuance of secured and/or unsecured NCDs/Bonds, in one or more tranches, on private placement basis, in 19th AGM.
05-Aug-2024 13-Aug-2024 Quarterly Results
17-May-2024 24-May-2024 Dividend & Audited Results
13-Mar-2024 15-Mar-2024 Inter alia, to consider the raising of funds through the issuance of any kind(s) of debt securities, in one or more tranches, whether domestic or international, as may be considered appropriate, subject to the regulatory and/or statutory approvals, as applicable
06-Feb-2024 14-Feb-2024 Quarterly Results
24-Jan-2024 28-Jan-2024 Right Issue of Equity Shares (Revised)
20-Jan-2024 24-Jan-2024 Right Issue of Equity Shares
15-Jan-2024 17-Jan-2024 Inter alia, to consider and approve: Raising of funds through issue of secured and/or unsecured debt and/or equity shares and/or any other convertible or exchangeable securities, including but not limited to, warrants, depository receipts, FCCBs, FCEBs or any combination thereof, by way of a public or preferential offer, a private placement, follow-on public offering, rights issue, qualified institutions placement or a combination thereof, or such other methods or combinations as may be decided, in India or abroad, as may be considered appropriate, subject to the regulatory and/or statutory approvals, as applicable.
07-Nov-2023 14-Nov-2023 Quarterly Results
Page 1 of 7
PREV || NEXT